Immune-related adverse events associated with immune checkpoint inhibitors: a call to action for collecting and sharing clinical trial and real-world data

Immune-related adverse events associated with immune checkpoint inhibitors: a call to action for collecting and sharing clinical trial and real-world data

Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of cancer, improving outcomes in patients with advanced malignancies. The use of ICIs in clinical practice, and the number of ICI clinical trials, are rapidly increasing. The use of ICIs in combination with other forms of cancer t...

Full description

Bibliographic Details
Main Authors: Sean Khozin, Osama Rahma, Meghan E Sise, Shaily Arora, Ravikumar Komandur Elayavilli, Aakanksha Khandelwal, Mace Rothenberg, Laura Petrillo, Alexandra-Chloe Villani
Format: Article
Language:English
Published: BMJ Publishing Group 2021-07-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/9/7/e002896.full

Internet

https://jitc.bmj.com/content/9/7/e002896.full

Similar Items